Pre-market hot trades in US stocks: Galmed Pharma pre-market down 9.09%; United Microelectronics pre-market down 7.09%

Pre-market Hot Trades in US Stocks

Galmed Pharma is down 9.09% in pre-market trading. Based on recent key news:

1. On July 16, Galmed partnered with Barcode Nanotech to develop an innovative Aramchol formulation that uses lipid nanoparticles (LPNs) to penetrate cardiac tissue. This unique formulation aims to shift the distribution of Aramchol from the liver to cardiac muscle, targeting drug delivery to address cardiac fibrosis issues, potentially revolutionizing treatment methods. However, there remains uncertainty regarding market acceptance of this new technology and its future commercialization prospects, leading to stock price volatility.

2. On July 16, risk factors mentioned in Galmed Pharma's annual report raised market concerns. The company detailed several risks in the report and emphasized that forward-looking statements should not be relied upon as predictions of future events. These uncertainties have increased cautious sentiment among investors, impacting stock price performance. The biopharmaceutical industry is characterized by frequent innovation, with risks and opportunities coexisting.

United Microelectronics is down 7.09% in pre-market trading. Based on recent key news:

1. On July 15, United Microelectronics announced the successful mass production of silicon photonic wafers in Singapore, targeting the AI infrastructure and high-speed optical communications markets. Despite the technological breakthrough, the stock price showed volatility in the Taiwan market, dropping nearly 5% at one point during the day, ultimately closing down 1.6%. Source: Zhitong Finance

2. On July 14, Citigroup analysts expressed optimism about United Microelectronics' outlook for the second half of the year, predicting a 13% quarter-over-quarter revenue growth and a rebound in gross margin. However, the market reacted poorly, and the stock price fell in the Taiwan market. Source: Jinshi Data

3. On July 15, analysts raised the target price for United Microelectronics to NT$92.5, indicating market confidence in its future performance, but the stock price still fluctuated with the broader market. Source: FactSet The silicon photonics market is experiencing significant growth, driven by AI demand.

Top Gainers in Pre-market US Stocks

Polestar is up 637.33% in pre-market trading. Based on recent key news:

1. On July 16, Lucid Motors faced bankruptcy rumors, which the company denied, but it impacted the electric vehicle market, affecting Polestar's stock price.

2. On July 17, the Chief Financial Officer of Volvo Cars stated there are currently no plans to inject capital into Polestar, raising concerns about Polestar's financial situation in the market.

3. On July 17, the CEO of Volvo Cars confirmed holding a 20% stake in Polestar and has no intention of changing the ownership ratio, stabilizing market expectations regarding Polestar's equity structure. The electric vehicle market faces risks of demand slowdown and policy changes.

Callan JMB is up 47.50% in pre-market trading. Based on recent news:

1. On July 16, the management team projected that the project would generate approximately $414 million in revenue for Callan JMB over the next five years and believes this will help create a cutting-edge pharmaceutical manufacturing environment in the United States. This news boosted market confidence, driving the stock price up

2. On July 17, Benzinga Pro data showed that Callan JMB closed at $0.86 during regular trading hours on Thursday, up 16.51%. Nevertheless, Benzinga's Edge stock ranking indicates that the price trend of CJMB shares is negative across all time frames.

3. On July 17, GrowHub announced a $400 million merger agreement with EnChem, causing its stock price to surge by 86%. This news has sparked investment enthusiasm in related industries, indirectly affecting the stock price of Callan JMB. The overall market volatility is significant, and investors should exercise caution.

Onfolio, pre-market up 36.33%, has had no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows notable volatility, and the specific reasons need further observation